XML 28 R12.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Composition of Certain Consolidated Financial Statement Items | 12 Months Ended
--- | ---
Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
Composition of Certain Consolidated Financial Statement Items | Composition of Certain Consolidated Financial Statement Items Inventory (in thousands):
|  |  | December 31,
|  |  | 2023 |  | 2022
Raw materials |  |  | $ | 16,737 |  |  | $ | 12,417 |
Work-in-process |  |  | 1,142 |  |  | 1,738 |
Finished goods |  |  | 21,877 |  |  | 14,388 |
Total inventory |  |  | $ | 39,756 |  |  | $ | 28,543 |
Property and Equipment, Net (in thousands):
|  |  | December 31,
|  |  | 2023 |  | 2022
Laboratory, manufacturing and computer equipment, and furniture and fixtures |  |  | $ | 15,610 |  |  | $ | 3,260 |
Rental equipment |  |  | 897 |  |  | 1,313 |
Leasehold improvements |  |  | 12,362 |  |  | 4,941 |
Evaluation units |  |  | — |  |  | 2,475 |
Construction in progress |  |  | 3,548 |  |  | 5,671 |
Total property and equipment |  |  | 32,417 |  |  | 17,660 |
Less: accumulated depreciation and amortization |  |  | (3,669) |  |  | (9,004) |
Total property and equipment, net |  |  | $ | 28,748 |  |  | $ | 8,656 |
Other Current Liabilities (in thousands):
|  |  | December 31,
|  |  | 2023 |  | 2022
Accrued purchases |  |  | 106 |  |  | 2,006 |
Professional services |  |  | 1,558 |  |  | 1,739 |
Sales tax |  |  | 1,725 |  |  | 829 |
Interest |  |  | 333 |  |  | 532 |
Travel expenses |  |  | 519 |  |  | 429 |
Asset retirement obligation |  |  | 232 |  |  | 200 |
Clinical trial expenses |  |  | 392 |  |  | 175 |
Other |  |  | 1,453 |  |  | 1,558 |
Total other current liabilities |  |  | $ | 6,318 |  |  | $ | 7,468 |
As of December 31, 2022, other non-current liabilities consisted of an asset retirement obligation for the facility lease which was terminated as of December 31, 2023. Interest and Other Income (Expense), net (in thousands):
|  |  | Year Ended December 31,
|  |  | 2023 |  | 2022 |  | 2021 |  |
Interest income |  |  | $ | 7,551 |  |  | $ | 2,497 |  |  | $ | 76 |  |  |
Decrease in fair value of preferred stock warrants |  |  | — |  |  | — |  |  | 64 |  |  |
Change in fair value of loan facility derivative liability |  |  | (107) |  |  | (283) |  |  | 135 |  |  |
Other |  |  | (176) |  |  | (203) |  |  | (154) |  |  |
Total interest and other income, net |  |  | $ | 7,268 |  |  | $ | 2,011 |  |  | $ | 121 |  |  |

X
- Definition The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement. + References No definition available. + Details
Name: | us-gaap_AdditionalFinancialInformationDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration